Anti-CARS antibody [EPR7121]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal CARS antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 4 publications.
View Alternative Names
CARS, CARS1, Cysteinyl-tRNA synthetase, CysRS
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CARS antibody [EPR7121] (AB126714)
ab126714 at 1/50 dilution stains CARS in paraffin-embedded human breast carcinoma tissue by immunohistochemistry.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-CARS antibody [EPR7121] (AB126714)
All lanes:
Western blot - Anti-CARS antibody [EPR7121] (ab126714) at 1/10000 dilution
Lane 1:
293T (Human embryonic kidney epithelial cell) cell lysate
Lane 2:
HeLa cell lysate
Lane 3:
U-87 MG (Human glioblastoma-astrocytoma epithelial cell line) cell lysate
Lane 4:
BxPC-3 cell lysate
Lane 5:
MCF-7 cell lysate
Lane 6:
A549 cell lysate
Predicted band size: 85 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-CARS antibody [EPR7121] (AB126714)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (1)
-
Anti-CARS antibody [EPR7121] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Cysteinyl-tRNA synthetase acts as an important component in the translation machinery ensuring incorporation of cysteine into growing polypeptide chains during protein synthesis. It forms part of the multi-synthetase complex (MSC) which is important for cellular translation and efficiency. Beyond its primary synthetase activity CARS also participates in additional cellular processes such as response to oxidative stress by regulating cytosolic thioredoxin levels.
Pathways
Cysteinyl-tRNA synthetase plays a significant role within the translation pathway aiding in the biosynthesis of proteins by providing the essential building blocks. Another critical pathway involving CARS is the response to oxidative stress where it interacts with proteins like thioredoxin supporting cellular defense mechanisms against oxidative damage. These interactions highlight its importance in maintaining cellular homeostasis and function.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Science advances 11:eady6386 PubMed40991712
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature cancer 3:471-485 PubMed35484422
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 11:654076 PubMed34046350
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 45: PubMed33846793
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com